CAI Caris Life Sciences
Caris Life Sciences earnings company data as of 4:45 AM ET 10/31
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 0.03 | — | — |
| Rev | $255.6M | — | — |
Insider trades
Open-market buys and sales by CAI's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $1.6M bought by 4 insiders
- $12.4M sold by 2 insiders outside a trading plan
- $1.7M sold by 1 insider under 10b5-1 plans
-
John Russel Denton See RemarksSale$239K 7,500 shares at $31.82 4.1% of stakeTraded Sep 22 Filed Sep 23
-
Brian J Brille See RemarksSale$12.1M 400,000 shares at $30.33 64% of stakeTraded Sep 17 Filed Sep 17
-
Jon Halbert DirectorBuy$990K 68,000 shares at $14.56 +11% to stakeTraded May 15 Filed Jul 13
-
Jeff L Vacirca DirectorBuy$501K 31,050 shares at $16.15 +167% to stakeTraded May 11 Filed May 12
-
Luke Thomas Power See RemarksPlanned sale$1.7M 62,250 shares at $26.58 39% of stakeTraded Dec 11, 2025 Filed Dec 12, 2025
-
David Baxley Spetzler PresidentBuy$9,540 400 shares at $23.85 +0.1% to stakeTraded Nov 7, 2025 Filed Nov 10, 2025
-
John Russel Denton See RemarksBuy$101K 4,184 shares at $24.09 +84% to stakeTraded Nov 7, 2025 Filed Nov 10, 2025
Also filed in the last 12 months, not counted as buying or selling: 21 stock grants, 6 option exercises, 5 share withholdings for taxes, 3 sales to cover taxes, and 2 gifts.
SEC filings
Recent issuer filings from EDGAR, 15 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 7.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.07 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 1.01,1.02,2.03 | Filing Doc | |
| 10-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.